| 2026-04-29 | FDA Drug | FDA Recall: Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharm | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharm | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-15 | FDA Drug | FDA Recall: Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-01 | FDA Drug | FDA Recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-01 | FDA Drug | FDA Recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-04-01 | FDA Drug | FDA Recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-03-11 | FDA Drug | FDA Recall: Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1, | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-03-11 | FDA Drug | FDA Recall: Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677- | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-03-11 | FDA Drug | FDA Recall: Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceut | Teva Pharmaceuticals USA, Inc | Class II | N/A |
| 2026-03-11 | FDA Drug | FDA Recall: Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1, | Teva Pharmaceuticals USA, Inc | Class II | N/A |